These 21 SNPs may drive aggressive PCa by acting through the oncogene MYC, the androgen receptor (AR) pathway, or through modulating known PCa biomarkers such as MSMB or KLK3, and genes involved in invasion, proliferation, suppression or metastasis. Here, MYC is linked to posterior cortical atrophy.